Added to YB: 2026-02-10
Pitch date: 2026-02-08
BSX [bullish]
Boston Scientific Corporation
+0.15%
current return
Author Info
Guardian Capital shares independent research on asymmetry in capital markets. Sign up for the newsletter.
Company Info
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Market Cap
$113.1B
Pitch Price
$75.61
Price Target
130.00 (+72%)
Dividend
N/A
EV/EBITDA
22.17
P/E
39.32
EV/Sales
6.18
Sector
Health Care Equipment and Supplies
Category
growth
GUARDIAN’S BET WITH BURRY - Boston Scientific Corporation
BSX: Strong Q4 beat (revenue $5.3B vs $5.25B est, EPS $0.80 vs $0.77) but stock crashed 17.5% on EP division miss & cautious 2026 guidance (10-11% growth). Trading at 0.93 PEG vs peers at 1.2-2.7x. Key catalysts: WATCHMAN AFib data, FARAPULSE adoption, Penumbra deal. $130 PT (71% upside) on re-rating.
Read full article (7 min)